| Accession Number: | 0001415889-22-004837 |
| Date: | 2022-05-09 |
| Issuer: | EDITAS MEDICINE, INC. (EDIT) |
| Original Submission Date: |
EATON BRUCE
C/O EDITAS MEDICINE, INC.
11 HURLEY ST.
CAMBRIDGE, MA 02141
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2022-05-09 | S | 297 | d | $13.11 | 66,544 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | sale was effected pursuant to a durable automatic sales instruction plan adopted by the reporting person on june 15, 2019, and represents the sale of shares by the issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on may 6, 2022. the sale does not represent a discretionary trade by the reporting person. |
| f2 | this transaction was executed in multiple trades at prices ranging from $12.8768 to $13.12. the price reported above reflects the weighted average purchase price. the reporting person hereby undertakes to provide upon request, to the sec staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. |
